| Financial Year |
March 31 2023 |
| Monetary Funds |
1,479,464,200.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
37,255,440.54 |
| Accounts Receivable |
4,800,301,499.94 |
| Advances to Suppliers |
388,985,304.21 |
| Other Receivables |
84,827,047.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,191,230,071.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
39,305,113.94 |
| Other Current Assets |
181,841,112.22 |
| Total Current Assets |
14,750,691,647.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
308,048,745.80 |
| Investment Properties |
31,533,002.36 |
| Fixed Assetes |
1,707,556,632.20 |
| Under-construction Projects |
112,665,471.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
420,999,768.43 |
| R&D expenses |
-- |
| Goodwill |
393,470.50 |
| Long-Term Deferred and Prepaid Expenses |
972,778.78 |
| Deferred Income Tax Assets |
177,994,407.65 |
| Other Non-Current Assets |
491,453,054.09 |
| Sub-Total of Non-Current Assets |
3,275,721,162.75 |
| Total Assets |
18,026,412,810.34 |
| Short-Term Loans |
2,518,245,216.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,407,454,193.55 |
| Accounts Payable |
4,600,957,864.83 |
| Accounts Received In Advance |
246,819.60 |
| Employee Compensation Payable |
67,325,194.12 |
| Taxes Payable |
91,406,798.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
237,338,124.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,013,174.32 |
| Other Current Liabilities |
80,450,064.08 |
| Sub-Total of Current Liabilities |
10,439,497,626.47 |
| Long-term Loans |
1,163,586,222.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,212,778,705.85 |
| Total Liabilities |
11,652,276,332.32 |
| Paid-In Capital(Or Share Stock) |
1,165,549,740.00 |
| Capital Surplus |
3,130,869,532.00 |
| Surplus Reserve |
196,387,990.41 |
| LESS:Treasury Stock |
130,010,755.22 |
| Undistributed Profits |
1,970,748,067.29 |
| Minority Stockholder's Interest |
40,591,903.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,333,544,574.48 |
| Owner's Equity（Stockholder's Equity） |
6,374,136,478.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,026,412,810.34 |
